Medical Condition News

RSS

Universal germline genetic testing catches missed cancer risks in older patients

Universal germline genetic testing of nearly 40,000 patients with solid tumors detected a substantial proportion of inherited gene variants that would have been missed by the standard germline testing approach that excludes those over age 50.

8 Oct 2026

Study links non-brain gene variant to anorexia risk

A gene primarily active in fat and muscles could make a person more susceptible to anorexia nervosa, a deadly eating disorder with one of the highest mortality rates of any psychiatric disease.

8 Oct 2026

Optogenetic therapy improves light sensitivity in people with retinitis pigmentosa

An international research team has reported new results from the first clinical cohort of blind people treated with an optogenetic therapy for advanced retinitis pigmentosa.

7 Oct 2026

Epilepsy drugs may reduce effectiveness of hormonal contraceptives

People with epilepsy who use certain hormonal birth control methods may be at risk for reduced contraceptive effectiveness because of interactions with certain antiseizure medications, according to a study published October 7, 2026, in Neurology, the medical journal of the American Academy of Neurology.

7 Oct 2026

Gut inflammation may explain food sensitivities in IBD patients

A new study, to be published in Gastroenterology, finds that gut inflammation can change the way gut bacteria break down food - possibly triggering immune reactions to foods that were previously fine to eat.

7 Oct 2026

MD Anderson announces new roadmap to eliminate cervical cancer in Texas

On behalf of a statewide coalition of Texas health systems, academic institutions, community organizations and advocates, The University of Texas MD Anderson Cancer Center today announced the Texas Lone Star Cervical Cancer Elimination Plan 2027-2032, a five-year roadmap to eliminate cervical cancer in Texas.

7 Oct 2026

Study uncovers a protective role for microglia in Parkinson's disease

Researchers at the University of Oxford have uncovered a previously unrecognized protective role for microglia, the brain's resident immune cells, in Parkinson's disease.

7 Oct 2026

Adults with ADHD face higher risk of developing dementia later in life

A new study led by University of Pittsburgh School of Medicine researchers finds that adults with attention-deficit/hyperactivity disorder (ADHD) face a significantly higher risk of developing dementia or mild cognitive impairment later in life.

7 Oct 2026

Dementia status influences end-of-life care decisions despite advance directives

People were about 19 percentage points less likely to recommend life-sustaining treatment for a seriously ill patient with dementia than for a patient without dementia, even when an advance directive requested life-sustaining care, according to new research from the University of Colorado Anschutz.

7 Oct 2026

Nerve-stimulation device enters human trials for cancer-related cachexia

The Terasaki Institute for Biomedical Innovation announced today that OnVagus, a medical device company incubating at the Institute, has received institutional and regulatory approval to begin the first human trial of its noninvasive nerve-stimulation device for patients experiencing cancer-related wasting.

7 Oct 2026

County analysis reveals deep geographic and racial heart disease disparities

Despite sustained declines in overall cardiovascular disease mortality in the U.S., disparities based on race, ethnicity and place still persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in JACC, the flagship journal of the American College of Cardiology (ACC).

7 Oct 2026

Childhood poverty increases risk of atherosclerosis in adulthood

People who grew up in low-income families are at greater risk of developing atherosclerosis in the coronary arteries later in life.

7 Oct 2026

New modeling reveals high societal value of early Alzheimer's care

New treatments that can slow the progression of Alzheimer's disease could provide significant lifetime benefits to patients and society, with even greater benefits when initiated earlier, according to new research from the USC Schaeffer Center for Health Policy & Economics.

7 Oct 2026